In order to study the effect of calcitonin on the bone collagen metabolism in osteolathyrism, male Wistar rats were placed on 0.1% aminoacetonitrile diet for 9 days. Porcine calcitonin dissolved in gelatin was concurrently administered in a dose of 0.1 MRC U/100g body weight for 8 days and on the 9th day 0.75 MRC U/100g body weight was given 3, 2 and 1hr respectively before sacrifice. Both bone collagen formation and maturation were examined by the determination of specific and total activities of 3H-hydroxyproline in bone collagen, and collagen resorption was examined by the estimation of the amount of hydroxyproline released into the incubation medium from metaphyses. Treatment of lathyritic rats with calcitonin diminished the concentration of serum calcium, phosphate, and rate of collagen resorption, but did not affect collagen formation and collagen maturation. Inhibitory effect of calcitonin on collagen resorption was more pronounced in osteolathyrism than under normal condition. It seemed that parathyroid glands did not play a vital role in the collagen resorption induced by osteolathyrism, since the resorption was not affected by parathyroidectomy. On the other hand, administration of calcitonin (every 0.8 MRC U/rat, 60 and 30min before sacrifice) also counteracted collagen resorption which was induced by low calcium diet and treatment with parathyroid hormone (PTH, 70 USP units).
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It is concluded that the effect of calcitonin on collagen metabolism resulted in primary inhibition of collagen resorption in osteolathyrism, and that calcitonin counteracted both PTH-dependent collagen resorption and PTH-independent collagen resorption induced by osteolathyrism.
Experimental osteolathyrism is one of the most well-investigated molecular diseases of connective tissue, manifested by abnormalities in the growth of cartilage and bones. The main effect of these changes is a marked increase in the content of soluble collagen in the tissue of animals (Tanzer. 1965) .
(AAN), and their analogs had been used widely to produce experimental osteolathyrism.
We have previously shown (Seyama et al., 1971 ) that AAN increases the amount of soluble collagen, accompanied by an increase in the degradation of bone collagen which then produces osteoporosis-like changes.
Recently, calcitonin, a hypocalcemic peptide hormone, was isolated and details of the effect of this hormone in mineral metabolism have been clarified (Friedman and Raisz, 1965; Aliapoulios et al., 1966; Johnston and Deiss, 1966; Wallach et al., 1967 Table  4 . was indicated in the previous report (Seyama et al., 1971) , but in lathyritic rats treated with calcitonin, a proportion of NSC to total collagen was not significantly altered in comparison with non-treated lathyritic rats. Table 4 is a comparison of specific, partial, and total activities of collagen in the calcitonin-treated and non-treated lathyritic rats. The product of specific activity and the amount of hydroxyproline in each collagen fraction of calvaria was expressed as the partial activity value. Total activity is the sum of partial activity of NSC and ISC. The total and partial activities of NSC and ISC were slightly increased in the calcitonin treated group, although not significant in this experiment. However, the ratio of partial activity of ISC to total activity of lathyritic calvaria (0.77) was equal to that of calcitonin-treated calvaria (0.77).
Collagen maturation

Collagen resorption in lathyritic rats
Our previous experiment indicated that the resoption of bone collagen was enhanced by the AAN treatment (Seyama et al., 1971) . Table 5 shows that the amount of total hydroxyproline released from metaphyses in lathyritic rats was decreased by calcitonin treatment but not the amount of free hydroxyproline. In intact rats, the amount of total and free hydroxyproline decreased only slightly by calcitonin treatment, but its value was not significant as indicated in Table 5 .
Relationship between collagen resorption and parathyroid function
Total hydroxyproline in the medium decreased significantly in intact rats by parathyroidectomy, but not in lathyritic rats. This fact suggests that the increased resorption of Table 7 . Effect of calcitonin on parathyroid hormone dependent collagen resorption (metaphyses) **P <0 .01 PTH: parathyroid hormone bone collagen found in osteolathyrism was scarcely dependent on parathyroid function (Table 6 ).
Parathyroid hormone dedendent collagen resorption Effect of calcitonin on the resorption of bone collagen induced by low-calcium diet and PTH injection is shown in Table 7 . From this result, calcitonin is known to counteract the PTH-dependent resorption of bone collagen.
Discussion
Currently accumulated evidence indicates that calcitonin lowers serum calcium by in hibiting bone resorption (Friedman and Raisz, 1965; Aliapoulios et al., 1966; Johnston and Deiss, 1966; Wallach et al., 1967) . Moreover calcitonin inhibits urinary hydroxyproline excretion in rats (Martin et al., 1966; Aer, 1968) . Because the rate of excretion of hydroxyproline is mainly in a measure of the rate of bone resorption, these findings suggest that calcitonin acts not only by preventing mineral removal from bone, but also by inhibiting bone collagen breakdown. In an experiment using cultured long bone, Raisz et al. (1968) found that calcitonin inhibited calcium removal but not the release of hydroxyproline. However, Heersche (1969) subsequently showed by using explanted calvaria of mouse embryo that calcitonin inhibits PTH-dependent resorption of the previously formed mineralized collagen but does not affect PTH-dependent resorption of newly formed collagen. These results indicate that calcitonin inhibits directly or indirectly the resorption of bone collagen.
It is now generally accepted that calcitonin is more effective in diseases in which there is in abnormally high rate of bone resorption; for example Paget's disease and hyperparathyroidism (Potts, 1970; Bell et al., 1970) . Therefore, it is suggested that calcitonin becomes a possible agent in the treatment of disorders of bone in which resorption is increased. The effect of calcitonin on experimentaly induced osteolysis has been studied by several investigators (Fujita et al., 1968; Jowesy, 1969; Singh and Jowesy 1970; Chiroff et al., 1970) . However, the action of calcitonin in metabolism of bone organic matrix, especially under pathological condition, is not yet known, Thus, in the present experiment the effect of calcitonin on collagen metabolism was investigated under a condition designated to alter the rate of collagen degradation and maturation.
Administration of calcitonin to lathyritic rats resulted in a significant hypocalcemia and hypophosphatemia. Although there were several experiments indicating that calcitonin increases bone formation (Wase et al., 1967; Foster et al., 1966; Gaillard, 1967) Selye (1958) already suggested that the development of osteolathyrism was not due to a primary lesion of an endocrine gland, it is not yet established whether the degradation of bone collagen is independent of the parathyroid function. PTH is well known to produce an increase in bone resorption. In our experimental system the increase of collagen resorption was observed by treatment with a low-calcium diet and PTH. Accordingly, AAN might produce its effect by releasing PTH from the parathyroid gland. To test this possibility, parathyroidectomy was carried out on lathyritic and intact rats before incubation of their metaphyses. The rate of collagen resorption did not decrease by parathyroidectomy in lathyritic rats but did so significantly in intact rats. It seemed that parathyroid glands did not play a vital role in the collagen resorption of metaphyses induced by osteolathyrism. This suggestion was also supported by the fact that serum phosphate tended to increase in lathyritic rats but decrease in rats treated with PTH. Hirsch (1964) already found that calcitonin decreases serum calcium concentration in parathyroidectomized rats. It was also suggested from our experiment that the inhibition of bone resorption by calcitonin was not dependent on the cause of induction of bone resorption. Although we cannot as yet explain the mechanism by which calcitonin reduces PTH-independent resorption of bone collagen, it seems likely that calcitonin not only competes with PTH at the same site of action, but also acts to inhibit bone resorption at a different site.
